Survey of hepatitis B virus infection status after 35 years of universal vaccination implementation in Taiwan
Liver International · 2024
DOI: 10.1111/liv.15959 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2024. Verfasst von Kai-Chi Chang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Hepatitis B Vaccines, Hepatitis B, Hepatitis B Surface Antigens, Hepatitis B virus. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Taiwan Centers for Disease Control, Department of Health, Taiwan Centers for Disease Control.
Abstract (Originalsprache)
Background and aims Hepatitis B virus (HBV) vaccination programs in Taiwan are one of the earliest programs in the world and have largely reduced the prevalence of HBV infection. We aimed to demonstrate the vaccination efficacy after 35 years and identify gaps toward HBV elimination.
Methods
A total of 4717 individuals aged 1–60 years were recruited from four administrative regions based on the proportion of population distribution. Serum levels of hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (anti‐HBs), and hepatitis B core antibody (anti‐HBc) levels were assessed. HBV viral load, genotypes and HBsAg ‘ ɑ ’ determinant variants were evaluated if indicated.
Results
After 35 years of vaccination, the overall seropositivity rates for HBsAg and anti‐HBc in Taiwan were 4.05% and 21.3%, respectively. The vaccinated birth cohorts exhibited significantly lower seropositivity rates for both markers compared to the unvaccinated birth cohorts (HBsAg: 0.64% vs. 9.78%; anti‐HBc: 2.1% vs. 53.55%, respectively; p < 0.0001). Maternal transmission was identified as the main route of HBV infection in breakthrough cases. Additionally, increased prevalences of genotype C and HBsAg escape mutants were observed.
Conclusion
The 35‐year universal HBV vaccination program effectively reduced the burden of HBV infection, but complete eradication of HBV infection has not yet been achieved. In addition to immunization, comprehensive screening and antiviral therapy for infected individuals, especially for pregnant women, are crucial strategies to eliminate HBV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan.
- Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
- Hepatitis Research Center, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan.
- Department and Graduate Institute of Medical Education and Bioethics, College of Medicine, National Taiwan University, Taipei, Taiwan.
- Centers for Disease Control, Ministry of Health and Welfare, Taipei, Taiwan.
ORCID-Profile: Kai-Chi Chang, Mei-Hwei Chang, Huey-Ling Chen, Jia-Feng Wu, Hong-Yuan Hsu, Yen-Hsuan Ni
Förderung
- Taiwan Centers for Disease Control, Department of Health
- Taiwan Centers for Disease Control
Zitieren
APA
Chang, K. C., Chang, M. H., Chen, H. L., Cheng, F. W., Wu, J. F., Su, W. J., Hsu, H. Y., & Ni, Y. H. (2024). Survey of hepatitis B virus infection status after 35 years of universal vaccination implementation in Taiwan. Liver International. https://doi.org/10.1111/liv.15959
Vancouver
Chang KC, Chang MH, Chen HL, Cheng FW, Wu JF, Su WJ, et al. Survey of hepatitis B virus infection status after 35 years of universal vaccination implementation in Taiwan. Liver International. 2024. doi:10.1111/liv.15959
BibTeX
@article{Chang2024,
author = {Chang, Kai-Chi and Chang, Mei-Hwei and Chen, Huey-Ling and Cheng, Fang-Wen and Wu, Jia-Feng and Su, Wei-Ju and Hsu, Hong-Yuan and Ni, Yen-Hsuan},
title = {Survey of hepatitis B virus infection status after 35 years of universal vaccination implementation in Taiwan},
journal = {Liver International},
year = {2024},
doi = {10.1111/liv.15959}
}
EUVIMED